Infection of mucosal epithelial cells by Neisseria gonorrhoeae

Reviews and Research in Medical Microbiology

Volumn 8, Issue 2, 1997, Pages 51-59

  Van Putten, Jos P M ^a   Duensing, Thomas D ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Gonococcal adherence; Mucosal surfaces; Neisseria gonorrhoeae; Pilus

Indexed keywords

OLIGOSACCHARIDE; OUTER MEMBRANE PROTEIN;

ADAPTATION; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ADHERENCE; EPITHELIUM CELL; GRAM NEGATIVE INFECTION; HOST RESISTANCE; HUMAN; HUMAN CELL; MUCOSA CELL; NEISSERIA GONORRHOEAE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; SURVIVAL;

EID: 0030981311     PISSN: 0954139X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00013542-199704000-00001     Document Type: Article

References (70)

1. Hook III EW, Holmes KK. Gonococcal infections. Ann Intern Med 1985; 102: 229-243.
2. Kellogg DS, Peacock WL, Deacon WE et al. Neisseria gonorrhoeae. I. Virulence genetically linked to clonal variation. J. Bacteriol 1963; 85: 1274-1279.
3. Brinton CC, Bryan J, Dillon JA et al. Uses of pili in gonorrhea control: role of bacterial pili in disease, purification and properties of gonococcal pili, and progress in the development of a gonococcal pilus vaccine for gonorrhea. In: Brooks GF et al, eds. Immunobiology of Neisseria gonorrhoeae, pp 155-178. Washington, DC, American Society for Microbiology: 1978.
4. Cohen MS, Cannon JG, Jerse AE et al. Human experimentation with Neisseria gonorrhoeae: rationale, methods, and implications for the biology of infection and vaccine development. J Infect Dis 1994; 169: 532-537.
5. Cannon JG, Cohen MS, Isbey SF et al. Infectivity of gonococcal mutants in the human challenge model. In: Zollinger WD, Frasch CE, Deal CD, eds. Tenth International Pathogenic Neisseria Conference, pp 11-12. Baltimore, USA, 1996.
6. Parge HE, Forest KT, Hickey MJ et al. Structure of the fibre-forming protein pilin at 2.6 Å resolution. Nature 1995; 378: 32-38.
7. Swanson J. Studies of gonococcal infection. IV. Pili: their role in attachment of gonococci to tissue culture cells. J Exp Med 1973; 137: 571-589.
8. Ward M, Watt PJ, Robertson JN. The human fallopian tube: a laboratory model for gonococcal infection. J Infect Dis 1974; 129: 650-659.
9. Boslego JW, Tramont EC, Chung RC et al. Efficacy trial of a parental gonococcal pilus vaccine in men. Vaccine 1991; 9: 154-162.
10. Johnson SC, Chung RCY, Deal CD et al. Human immunization with Pgh 3-2 gonococcal pilus results in cross-reactive antibody to the cyanogen bromide fragment-2 of pilin. J Infect Dis 1991; 163: 128-134.
11. Meyer TF, Pohlner J, van Putten JPM. Biology of the pathogenic neisseriae. Curr Top Microbiol Immun 1994; 192: 283-317.
12. Forest KT, Bernstein SL, Getzoff ED et al. Assembly and antigenicity of the Neisseria gonorrhoeae pilus mapped with antibodies. Infect Immun 1996; 64: 644-652.
13. Swanson J, Robbins K, Barrera O et al. Gonococcal pilin variants in experimental gonorrhea. J Exp Med 1987; 165: 1344-1357.
14. Seifert HS, Wright CJ, Jerse AE et al. Multiple gonococcal pilin antigenic variants are produced during experimental human infections. J Clin Invest 1994; 93: 2744-2749.
15. Duckworth M, Jackson D, Zak K et al. Structural variation in pili expressed during gonococcal infection. J Gen Microbiol 1983; 129: 1593-1596.
16. Lambden PR, Robertson JN, Watt PJ. The preparation and properties of a-pili and β-pili from variants of Neisseria gonorrhoeae P9. J Gen Microbiol 1981; 124: 109-117.
17. Schoolnik GK, Fernandez R, Tai JY et al. Gonococcal pili. Primary structure and receptor binding domain. J Exp Med 1984; 159: 1351-1370.
18. Rudel T, van Putten JPM, Gibbs CP et al. Interaction of two variable proteins (PilE and PilC) required for pilus-mediated adherence of Neisseria gonorrhoeae to human epithelial cells. Mol Microbiol 1992; 6: 3439-3450.
19. Jonsson AB, Ilver D, Falk P et al. Sequence changes in the pilus subunit lead to tropism of Neisseria gonorrhoeae to human tissue. Mol Microbiol 1994; 13: 403-416.
20. Jonsson AB, Nyberg G, Normark S. Phase variation of gonococcal pili by frame shift mutation in pilC, a novel gene for pilus assembly. EMBO J 1991; 10: 477-488.
21. Rudel T, Scheuerpflug I, Meyer TF. Neisseria PilC protein identified as type-4 pilus tip-located adhesin. Nature 1995; 373: 357-359.
22. Swanson J, Barrera O, Sola J et al. Expression of outer membrane protein II by gonococci in experimental gonorrhea. J Exp Med 1988; 168: 2121-2129.
23. Jerse AE, Cohen MS, Drown PM et al. Multiple gonococcal opacity proteins are expressed during experimental infection in the male. J Exp Med 1994; 179: 911-920.
24. Shafer WM, Rest RF. Interactions of gonococci with phagocytic cells. Ann Rev Microbiol 1989; 43: 121-145.
25. Bhat KS, Gibbs CP, Barrera O et al. The repertoire of opacity proteins displayed by Neisseria gonorrhoeae MS11 outer surface are encoded by a family of 11 complete genes. Mol Microbiol 1991; 5: 1889-1901; Corrigendum 1992; 6: 1073-1076.
26. Lambden PR, Heckels JE, James LT et al. Variation in surface protein composition associated with virulence properties in opacity types of Neisseria gonorrhoeae. J Gen Microbiol 1979; 114: 305-312.
27. Bessen D, Gotschlich EC. Interactions of gonococci with HeLa cells: attachment, detachment, replication, penetration, and the role of protein II. Infect Immun 1986; 54: 154-160.
28. Makino S, van Putten JPM, Meyer TF. Phase variation of the opacity outer membrane protein controls invasion by Neisseria gonorrhoeae into human epithelial cells. EMBO J 1991; 10: 1307-1315.
29. Van Putten JPM, Paul SM. Binding of syndecan-like cell surface proteoglycan receptors is required for Neisseria gonorrhoeae entry into human mucosal cells. EMBO J 1995; 14: 2144-2154.
30. Van Putten JPM, Grassmé HUC, Robertson BD et al. Function of lipopolysaccharide in the invasion of Neisseria gonorrhoeae into human mucosal cells. Prog Clin Biol Res 1995; 392: 49-58.
31. Simon D, Rest RF. Escherichia coli expressing Neisseria gonorrhoeae opacity associated membrane protein invade human cervical and endometrial epithelial cells. Proc Natl Acad Sci USA 1992; 89: 5512-5516.
32. Simon D, Hingley SST, Rest RF. Interaction of human epithelial cell lines and neutrophils of Escherichia coli expressing gonococcal Opa protein. In: Conde-Glez CJ, Morse S, Rice P et al, eds. Pathobiology and Immunobiology of Neisseriaceae. Cuernavaca, Mexico: Instituto Nacional de Salud Publica, 1994: 758-764.
33. Waldbeser LS, Ajioka RS, Merz AJ et al. The opaH locus of Neisseria gonorrhoeae MS11A is involved in epithelial cell invasion. Mol Microbiol 1994; 13: 919-928.
34. Purachuri DK, Seifert US, Ajioka RS et al. Identification and characterization of a Neisseria gonorrhoeae gene encoding a glycolipid-binding adhesin. Proc Natl Acad Sci USA 1990; 87: 333-337.
35. van Putten JPM, Robertson BD. Molecular mechanisms and implications for infection of lipopolysaccharide variation in Neisseria. Mol. Microbiol 1995; 16: 847-853.
36. Danaher RJ, Levin JC, Arking D et al. Genetic basis of Neisseria gonorrhoeae lipooligosaccharide antigenic variation. J Bacteriol 1995; 172: 7275-7279.
37. Yang QL, Gotschlich EC. Variation of gonococcal lipoligosaccharide structure is due to alterations in poly-G tracts in lgt genes encoding glycosyltransferases. J Exp Med 1996; 183: 323-327.
38. Porat N, Apicella MA, Blake MS. Neisseria gonorrhoeae utilizes and enhances the biosynthesis of the asialoglycoprotein receptor expressed on the surface of the hepatic HepG2 cell line. Infect Immun 1995; 63: 1498-1506.
39. Lucas CT, Chandler F, Martin JE et al. Transfer of gonococcal urethritis from man to chimpanzee. An animal model for gonorrhea. JAMA 1971; 216: 1612-1614.
40. Johnson AP, Taylor-Robinson D, McGee ZA. Species specificity and damage to oviduct mucosa by Neisseria gonorrhoeae. Infect Immun 1977; 18: 833-839.
41. McGee ZA, Gregg CR, Johnson AP et al. The evolutionary watershed of susceptibility to gonococcal infection. Microb Pathogenesis 1990; 9: 131-139.
42. Buchanan TM, Pearce WA, Chen KCS. Attachment of Neisseria gonorrhoeae pili to human cells, and investigations of the chemical nature of the receptor for gonococcal pili. In: Brooks GF et al, eds. Immunobiology of Neisseria gonorrhoeae, pp 242-249. Washington, DC, American Society for Microbiology: 1978.
43. Källström H, Rahman M, Jonsson AB. Characterization of a eukaryotic pilus receptor for Neisseria gonorrhoeae and Neisseria meningitidis. In: Zollinger WD, Frasch CE, Deal CD, eds. Tenth International Pathogenic Neisseria Conference. Baltimore, USA, 1996: 289.
44. Bessen D, Gotschlich EC. Chemical characterization of binding properties of opacity-associated protein II from Neisseria gonorrhoeae. Infect Immun 1987; 55: 141-147.
45. Chen T, Belland RJ, Wilson J et al. Adherence of pilus - Opa+ gonococci to epithelial cells in vitro involves heparan sulfate. J Exp Med 1995; 182: 511-517.
46. Virji M, Watt SM, Barker S et al. CD66 adhesion molecules on polymorphonuclear phagocytes and epithelial cells are targets for Opa proteins of Neisseria meningitidis and Neisseria gonorrhoeae. In: Zollinger WD, Frasch CE, Deal CD, eds. Tenth International Pathogenic Neisseria Conference. Baltimore, USA, 1996: 318-319.
47. Ward ME, Robertson JN, Englefield PM et al. Gonococcal infection: invasion of mucosal surfaces of the genital tract. In: Schlessinger D, ed. Microbiology 1975, pp 188-199. Washington, DC: American Society for Microbiology, 1975.
48. Evans BA. Ultrastructural study of cervical gonorrhoea. J Infect Dis 1977; 136: 248-255.
49. Apicella MA, Ketterer M, Lee FKN et al. The pathogenesis of gonococcal urethritis in men: confocal and immunoelectron microscopic analysis of urethral exudates from men infected with Neisseria gonorrhoeae. J Infect Dis 1996; 636-646.
50. McGee ZA, Clemens CM, Jensen RL et al. Local induction of tumor necrosis factor as a molecular mechanism of mucosal damage by gonococci. Microb Pathogenesis 1992; 12: 333-341.
51. Tjia KF, van Putten JPM, Pels E et al. The interaction between Neisseria gonorrhoeae and the human cornea in organ culture: an electron microscopic study. Graefe's Arch Clin Exp Opthalmol 1988; 226: 341-345.
52. Grassmé HUC, Ireland RM, van Putten JPM. Gonococcal opacity protein promotes bacterial entry-associated rearrangements of the epithelial cell actin cytoskeleton. Infect Immun 1996; 64: 1621-1630.
53. Chen JCR, Bavoil P, Clark VL. Enhancement of the invasive ability of Neisseria gonorrhoeae by contact with Hec1B, an adenocarcinoma endometrial cell line. Mol Microbiol 1991; 5: 1531-1538.
54. Spence JM, Clark VL. The role of lutropin receptor in gonococcal invasion of Hec1B cells: a preliminary report. In: Zollinger WD, Frasch CE, Deal CD, eds. Tenth International Pathogenic Neisseria Conference. Baltimore, USA, 1996: 310-311.
55. Van Putten JPM. Phase variation of lipopolysaccharide directs interconversion of invasive and immuno-resistant phenotypes of Neisseria gonorrhoeae. EMBO J 1993; 12: 4043-4051.
56. Schneider H, Schmidt KA, Skillman D et al. Sialylation lessens infectivity of Neisseria gonorrhoeae MS11mkC. J Infect Dis 1996; 173: 1422-1427.
57. Schneider H, Cross AS, Kuschner RA et al. Experimental human gonococcal urethritis: 250 Neisseria gonorrhoeae MS11mkC are infective. J Infect Dis 1995; 172: 1809-1815.
58. Porat N, Apicella MA, Blake MS. A lipooligosaccharide-binding site on HepG2 cells is similar to the gonococcal Opacity-associated surface protein Opa. Infect Immun 1995; 63: 2164-2172.
59. Wyrick PB, Choong J, Davies CH et al. Entry of genital Chlamydia trachomatis into polarized human epithelial cells. Infect Immun 1989; 57: 2378-2389.
60. Francis CL, Ryan TA, Jones BD et al. Ruffles induced by Salmonella and other stimuli direct macropinocytosis of bacteria. Nature (London) 1993; 364: 639-642.
61. Isberg RR, Tran van Nhieu TG. Two mammalian cell internalization strategies used by pathogenic bacteria. Trends Microbiol 1994; 2: 10-14.
62. Rapraeger A, Jalkanen M, Bernfield M. Cell surface proteoglycan associates with the cytoskeleton at the basolateral cell surface of mouse mammary epithelial cells. J Cell Biol 1986; 103: 2683-2696.
63. Jackson T, Ellard FM, Ghazaleh RA et al. Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate. J Virol; 70: 5282-5287.
64. Blake MS, Gotschlich E. Gonococcal membrane proteins: speculation on their role in pathogenesis. Prog Allergy 1983; 33: 298-313.
65. Weel JFL, Hopman CTP, van Putten JPM. Bacterial entry and intracellular processing of Neisseria gonorrhoeae in epithelial cells: immunomorphological evidence for alterations in the major outer membrane protein P.IB. J Exp Med 1991; 174: 705-717.
66. 2-generation. J Biol Chem 1988; 263: 945-951.
67. Bjerkness R, Guttormsen HK, Solberg CO et al. Neisserial porins inhibit human neutrophil actin polymerization, degranulation, opsonin receptor expression, and phagocytosis but prime neutrophils to increase their oxidative burst. Infect Immun 1995; 63: 160-167.
68. Sparling PF, Elkins C, Wyrick PB et al. Vaccines for bacterial sexually transmitted infections: a realistic goal? Proc Natl Acad Sci USA 1994; 91: 2456-2463.
69. Blake MS, Wetzler LM. Vaccines for gonorrhea: where are we on the curve? Trends Microbiol 1995; 3: 469-474.
70. Cohen MS, Isbey SF, Charniga et al. In vivo experi- ments with Neisseria gonorrhoeae. In: Evans JS, Yost SE, Maiden MCJ et al, eds. Proceedings of the Ninth International Neisseria Conference. Winchester, UK, 1994: 223-224.